This is our modified version of Pharma Bold 500. Thanks to the high percentage drug synthesis implementation technologies we were able to create almost a double concentrated drug compared to Pharma Bold 500.
WARNING: If you are going to use a high concentration drug for the first time, it is highly recommended to inject only ½ ml to control the body reaction and to prevent possible side effects, which can include post injection pain (PIP), high body temperature , lumps, etc.
Boldenone (also known as Equipoise) was developed as a long version of methandienone and patented by Ciba as a synthetic anabolic steroid in 1949. However, the result was a steroid with completely different properties, despite the chemical similarity. Boldenone was developed primarily for the treatment of dystrophy and to increase bone weight and density in osteoporosis.
Boldenone is a long-term injectable steroid that exhibits strong anabolic and moderately androgenic properties. The low androgenic properties allow boldenone for women to use. Virilization rarely, compared to other steroids. Boldenone is one of the few injectable drugs that can be taken by female athletes without the risk of side effects.
Boldenone enormously stimulates hematopoiesis. High levels of red blood cells improve the supply of oxygen to the muscles. This makes this steroid attractive to track and field athletes.
Athletes who take boldenone often report slow but high muscle growth. All the positive effects of the drug become evident in long cycles (12 weeks or more). The muscles on the boldenone cycle will be denser than the muscles on testosterone. Boldenone does not retain water in the muscles, so their volume after the cycle must be the same as that of the cycle. The drug increases the rate of potency and significantly increases appetite.